{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:38:35Z","timestamp":1790717915891,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cardiovascular disease remains the leading global cause of death, and a major part of its residual risk is now understood to be inflammatory rather than purely lipid-driven. Immunometabolism provides the missing link between metabolic stress and immune activation: excess lipids, hyperglycemia, and tissue hypoxia reprogram immune and vascular cells toward glycolysis, altered glutamine use, mitochondrial dysfunction, and durable epigenetic memory. In atherosclerosis, this metabolic shift fuels endothelial dysfunction, macrophage foam-cell formation, cytokine release, defective efferocytosis, and plaque instability. The concept extends beyond the plaque itself through trained immunity, in which monocytes and bone marrow progenitors retain a pro-inflammatory memory that can persist after the original trigger has passed. This helps explain why myocardial infarction, diabetes, and hyperlipidemia can leave a long inflammatory imprint on the vasculature. Immunometabolism also contributes to thromboinflammation, where activated platelets, neutrophils, and extracellular traps reinforce clot formation and amplify arterial injury. In heart failure, postischemic remodeling and chronic congestion are accompanied by immune-cell and cardiomyocyte metabolic remodeling that sustains inflammation, fibrosis, and adverse ventricular remodeling. Clinical trials targeting inflammation, especially canakinumab and low-dose colchicine, have shown that suppressing inflammatory pathways can reduce cardiovascular events, supporting the translational value of this biology. A clearer understanding of immunometabolic circuits may enable better risk stratification, biomarker-guided therapy, and new treatments that simultaneously stabilize plaques, reduce thrombosis, and improve postinfarction healing.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000001391","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:00:06Z","timestamp":1783152006000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes"],"prefix":"10.1097","author":[{"given":"Saneha","family":"Rani","sequence":"first","affiliation":[{"name":"People University of Medical and Sciences for Women, Nawabshah, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda","family":"Aimen Gillani","sequence":"additional","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimsha","family":"Naseer","sequence":"additional","affiliation":[{"name":"Allama Iqbal Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahroo","family":"Khalid","sequence":"additional","affiliation":[{"name":"Punjab Medical College, Faisalabad Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areena","family":"Fatima","sequence":"additional","affiliation":[{"name":"Quaid e Azam Medical College, Bahawalpur, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Akram","sequence":"additional","affiliation":[{"name":"Quaid e Azam Medical College, Bahawalpur, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaad","family":"Dilshad","sequence":"additional","affiliation":[{"name":"Quaid e Azam Medical College, Bahawalpur, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"R1-20260706","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260706","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/ATVBAHA.120.314216","article-title":"Trained immunity in atherosclerotic cardiovascular disease.","volume":"41","author":"Flores-Gomez","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-20260706","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014From experimental insights to the clinic.","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat Rev Drug Discovery"},{"key":"R4-20260706","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/s42255-024-01015-w","article-title":"Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities.","volume":"6","author":"Stroope","year":"2024","journal-title":"Nat Metab"},{"key":"R5-20260706","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"R6-20260706","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy andsafety of low-dose colchicine after myocardial infarction.","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"R7-20260706","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease.","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"R8-20260706","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists.","volume":"16","author":"O\u2019Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R9-20260706","first-page":"884","article-title":"Immunometabolism at the heart of cardiovascular disease.","volume":"8","author":"DeBerge","year":"2023","journal-title":"Basic Trans Sci"},{"key":"R10-20260706","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2018.07.030","article-title":"Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers.","volume":"174","author":"Murphy","year":"2018","journal-title":"Cell"},{"key":"R11-20260706","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s42255-025-01354-2","article-title":"Slc7a7 licenses macrophage glutaminolysis for restorative functions in atherosclerosis.","volume":"7","author":"Benhmammouch","year":"2025","journal-title":"Nat Metab"},{"key":"R12-20260706","doi-asserted-by":"crossref","first-page":"2500610","DOI":"10.1002\/advs.202500610","article-title":"Wogonin attenuates atherosclerosis via KLF11\u2010mediated suppression of PPAR\u03b1\u2010YAP1\u2010Driven glycolysis and enhancement of ABCA1\/G1\u2010mediated cholesterol efflux.","volume":"12","author":"Ma","year":"2025","journal-title":"Adv Sci"},{"key":"R13-20260706","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1093\/cvr\/cvad030","article-title":"Innate immune memory in cardiometabolic disease.","volume":"119","author":"Bahrar","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R14-20260706","doi-asserted-by":"crossref","first-page":"e23231","DOI":"10.1096\/fj.202301078R","article-title":"Trained immunity in diabetes and hyperlipidemia: emerging opportunities to target cardiovascular complications and design new therapies.","volume":"37","author":"Robinson","year":"2023","journal-title":"FASEB J"},{"key":"R15-20260706","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/ehad787","article-title":"Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis.","volume":"45","author":"Dong","year":"2024","journal-title":"Eur Heart J"},{"key":"R16-20260706","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway.","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"key":"R17-20260706","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/eurheartj\/ehaf982","article-title":"Trained immunity in cardiovascular disease.","volume":"47","author":"Riksen","year":"2026","journal-title":"Eur Heart J"},{"key":"R18-20260706","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","article-title":"Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.","volume":"43","author":"Haghikia","year":"2022","journal-title":"Eur Heart J"},{"key":"R19-20260706","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week.","volume":"72","author":"Libby","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260706","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis.","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"key":"R21-20260706","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41392-025-02198-8","article-title":"Platelets anddiseases: signal transduction and advances in targeted therapy.","volume":"10","author":"Tian","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R22-20260706","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited.","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"R23-20260706","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation-cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr Heart Fail Rep"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:00:15Z","timestamp":1783324815000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":23,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001391","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]}}}